CompletedNCT00088036

Olanzapine for Borderline Personality Disorder

This study is completed in the United States, in Argentina, in Poland, .... It is testing olanzapine for Borderline Personality Disorder.

Personality disorders, Borderline personalityDrugFrom 18 Years to 65 Years

The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations: National City, United States · New Haven, United States and 13 more locationsSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2004

Recruitment status: Completed
Enrollment listed in the registry: 450
Sponsor: Eli Lilly and Company
Sponsor type: Other organization
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: United States, Argentina, Poland, ...
Age range: From 18 Years to 65 Years
Official registry ID: NCT00088036
Official title: Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Double-Blind Comparison With Placebo

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: NCT00088036. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Completed

National City, United States · New Haven, United States · Indianapolis, United States

13 more locations

Jackson, United States
The Bronx, United States
Memphis, United States
Houston, United States
Capital Federal, Argentina
La Plata, Argentina
Villa Alberdi, Argentina
Buenos Aires, Argentina
Choroszcz, Poland
Torun, Poland
Bucharest, Romania
Istanbul, Türkiye
Türkiye

Registry details

Registry conditions (original wording)

Borderline Personality Disorder

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Does this study involve medication?

Yes. The study involves medication, including Olanzapine.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as completed.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me